Home/Filings/4/0001104659-22-020894
4//SEC Filing

Manning Linda Shapiro 4

Accession 0001104659-22-020894

CIK 0001649904other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 9:34 PM ET

Size

8.1 KB

Accession

0001104659-22-020894

Insider Transaction Report

Form 4
Period: 2022-02-09
Manning Linda Shapiro
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-09+75,00075,000 total
    Exercise: $6.80Exp: 2032-02-08Common Stock (75,000 underlying)
  • Award

    Restricted Stock Units

    2022-02-09+12,50012,500 total
    Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F3]The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1
  • filerCIK 0001883256

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:34 PM ET
Size
8.1 KB